Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02365597
Title An Efficacy and Safety Study of JNJ-42756493 in Participants With Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

urinary system cancer

Therapies

Erdafitinib

Age Groups: adult
Covered Countries USA | FRA | ESP | DEU | BEL | AUT

Facility Status City State Zip Country Details
Sedona Arizona United States Details
Los Angeles California United States Details
Orange California United States Details
Sacramento California United States Details
Stanford California United States Details
Aurora Colorado United States Details
Washington District of Columbia United States Details
Chicago Illinois United States Details
Iowa City Iowa United States Details
Louisville Kentucky United States Details
Minneapolis Minnesota United States Details
Omaha Nebraska United States Details
Las Vegas Nevada United States Details
New York New York United States Details
Charlotte North Carolina United States Details
Medford Oregon United States Details
Tualatin Oregon United States Details
Hershey Pennsylvania United States Details
Pittsburgh Pennsylvania United States Details
Myrtle Beach South Carolina United States Details
Nashville Tennessee United States Details
Dallas Texas United States Details
Denton Texas United States Details
Houston Texas United States Details
Hampton Virginia United States Details
Graz Austria Details
Linz Austria Details
Vienna Austria Details
Aalst Belgium Details
Brussel Belgium Details
Charleroi Belgium Details
Gent Belgium Details
Wilrijk Belgium Details
ANGERS Cedex France Details
Bordeaux France Details
Caen Cédex 05 France Details
Dijon France Details
Lyon France Details
Nice Cedex 2 France Details
Nîmes France Details
Paris Cedex 10 France Details
Paris Cedex 15 France Details
Saint Herblain Cedex France Details
Suresnes France Details
Villejuif Cedex France Details
Berlin Germany Details
Erlangen Germany Details
Essen Germany Details
Freiburg Germany Details
Greifswald Germany Details
Göttingen Germany Details
Hamburg Germany Details
Hannover Germany Details
Heidelberg Germany Details
Muenchen Germany Details
Muenster Germany Details
Regensburg Germany Details
Straubing Germany Details
Weiden/Opf Germany Details
Bangalore India Details
Kolkata India Details
Mira Road (East) India Details
Nadiad India Details
Be'er Sheva Israel Details
Beer Yaakov Israel Details
Haifa Israel Details
Kfar-Saba Israel Details
Petah Tikva Israel Details
Tel-Aviv Israel Details
Daejeon Korea, Republic of Details
Goyangsi Korea, Republic of Details
Incheon Korea, Republic of Details
Seoul Korea, Republic of Details
Chisinau Moldova, Republic of Details
Bucharest Romania Details
Cluj-Napoca Romania Details
Craiova Romania Details
Iasi Romania Details
Barnaul Russian Federation Details
Moscow N/a Russian Federation Details
Moscow Russian Federation Details
Omsk Russian Federation Details
Pyatigorsk Russian Federation Details
Saint-Petersburg Russian Federation Details
Sankt-Peterburg Russian Federation Details
Ufa Russian Federation Details
Badalona Spain Details
Barcelona Spain Details
Madrid Spain Details
Málaga Spain Details
Pamplona Spain Details
Sabadell Spain Details
Santander Spain Details
Santiago de Compostela Spain Details
Sevilla Spain Details
Valencia Spain Details
Taichung Taiwan Details
Tainan Taiwan Details
Taipei Taiwan Details
Taoyuan Taiwan Details
Istanbul Turkey Details
Blackburn United Kingdom Details
Dundee United Kingdom Details
Essex United Kingdom Details
London United Kingdom Details
Plymouth United Kingdom Details
Sutton United Kingdom Details
Wirral United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field